Buying factors: primary schools and kindergartens in Hong Kong have been suspended for two weeks due to the spread of influenza. Who has discussed whether to raise the alert level and the highest level of phase 6. Individual pharmaceutical stocks have been speculated high and have been authorized to produce H1N1 influenza A.

The vaccine's Sea King Interlon rose 15.2% throughout the day, reaching as high as 1.84 yuan, with a turnover of 16.8 million shares, and the current price is still not in the seriously overbought area, so you can still consider waiting for an opportunity to follow up.

At present, there are 11 seasonal influenza vaccine manufacturers in China, one of which is qualified to produce pandemic influenza vaccine. Eleven influenza vaccine manufacturers can immediately put into production and produce the first batch of vaccines by the end of July, with an output of 3 million doses and an annual production capacity of 360 million doses.

Purchase price: 1.80 yuan (current price 1.82 yuan)

Target price: 2.00 yuan

Stop-corrosion price: 1.60 yuan